We are live on
!
Find out more
Marshall Wace Portfolio holdings
AUM
$100B
1-Year Est. Return
35.1%
This Fund
S&P 500
This Quarter
Est. Return
+3.64%
1 Year Est. Return
+35.1%
3 Year Est. Return
+111.04%
5 Year Est. Return
+146.93%
10 Year Est. Return
+631.22%
AUM
$74.9B
AUM Growth
+$9.23B
(+14%)
Cap. Flow
+$7.27B
Cap. Flow
% of AUM
9.7%
Top 10 Holdings %
Top 10 Hldgs %
32.66%
Holding
3,137
New
748
Increased
792
Reduced
857
Closed
654
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares Core S&P 500 ETF
IVV
|
+$3.04B |
| 2 |
Microsoft
MSFT
|
+$830M |
| 3 |
Amazon
AMZN
|
+$550M |
| 4 |
Johnson & Johnson
JNJ
|
+$483M |
| 5 |
Apple
AAPL
|
+$470M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Procter & Gamble
PG
|
+$474M |
| 2 |
Alphabet (Google) Class A
GOOGL
|
+$435M |
| 3 |
Vanguard S&P 500 ETF
VOO
|
+$428M |
| 4 |
Alphabet (Google) Class C
GOOG
|
+$371M |
| 5 |
Micron Technology
MU
|
+$275M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 18.7% |
| 2 | Consumer Discretionary | 13.75% |
| 3 | Healthcare | 12.4% |
| 4 | Financials | 7.81% |
| 5 | Industrials | 6.28% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
776
Denison Mines
DNN
$2.63B
| $8.64M | 0.01% |
4,343,530
-3,333,443
| -43% | -$7.08M |
|
|
AXNX
777
DELISTED
Axonics, Inc. Common Stock
AXNX
| $8.63M | 0.01% |
128,321
-29,589
| -19% | -$1.99M |
|
778
Sonos
SONO
$1.75B
| $8.62M | 0.01% |
584,278
-753,591
| -56% | -$12.5M |
|
779
Sociedad Química y Minera de Chile
SQM
$19.6B
| $8.59M | 0.01% |
+210,852
| New | +$9.74M |
|
780
Rivian
RIVN
$22.9B
| $8.57M | 0.01% |
638,277
-652,479
| -51% | -$6.82M |
|
781
STAAR Surgical
STAA
$1.16B
| $8.56M | 0.01% |
179,704
-28,293
| -14% | -$1.24M |
|
782
PUT
Coinbase
COIN
$41.7B
| $8.53M | 0.01% |
38,400
+7,600
| +25% | +$1.75M |
|
783
Prestige Consumer Healthcare
PBH
$2.35B
| $8.53M | 0.01% |
123,920
+7,696
| +7% | +$521K |
|
784
NovoCure
NVCR
$2.04B
| $8.52M | 0.01% |
497,474
-272,053
| -35% | -$4.78M |
|
785
TJX Companies
TJX
$170B
| $8.49M | 0.01% |
77,122
-284,995
| -79% | -$28.7M |
|
786
Healthcare Services Group
HCSG
$1.56B
| $8.49M | 0.01% |
802,053
-7,493
| -0.9% | -$83.1K |
|
787
CALL
iShares Russell 2000 ETF
IWM
$80.9B
| $8.46M | 0.01% |
41,700
-393,700
| -90% | -$79.6M |
|
788
Upstart Holdings
UPST
$2.58B
| $8.46M | 0.01% |
358,459
-98,644
| -22% | -$2.38M |
|
789
Immunocore
IMCR
$1.78B
| $8.43M | 0.01% |
248,654
+30,703
| +14% | +$1.57M |
|
790
iShares Russell 1000 Growth ETF
IWF
$122B
| $8.42M | 0.01% |
92,400
-243,472
| -72% | -$20.8M |
|
791
Palomar
PLMR
$3.65B
| $8.42M | 0.01% |
103,757
-75,696
| -42% | -$6.17M |
|
792
Green Plains
GPRE
$1.19B
| $8.4M | 0.01% |
529,943
-554,451
| -51% | -$10.7M |
|
793
Centene
CNC
$31.3B
| $8.37M | 0.01% |
+126,300
| New | +$9.19M |
|
794
Mastercard
MA
$477B
| $8.31M | 0.01% |
18,847
-579,771
| -97% | -$264M |
|
795
Annexon
ANNX
$855M
| $8.3M | 0.01% |
1,693,665
+1,378,053
| +437% | +$7.13M |
|
796
Gilead Sciences
GILD
$161B
| $8.27M | 0.01% |
+120,516
| New | +$8.04M |
|
797
Ionis Pharmaceuticals
IONS
$9.35B
| $8.25M | 0.01% |
173,199
+157,756
| +1,022% | +$6.47M |
|
798
KBR
KBR
$4.68B
| $8.17M | 0.01% |
127,415
+105,067
| +470% | +$6.79M |
|
799
Invesco S&P 500 Momentum ETF
SPMO
$21.1B
| $8.13M | 0.01% |
92,951
+64,044
| +222% | +$5.2M |
|
800
Mueller Water Products
MWA
$3.92B
| $8.09M | 0.01% |
+451,300
| New | +$7.76M |
|
Similar funds
Marshall Wace's Q2 2024 Portfolio in Review
As of Q2 2024, Marshall Wace held 3,137 positions worth $74.9B, up 14% from $65.7B the previous quarter. Its ten largest holdings account for 33% of the portfolio.
Marshall Wace deployed $7.27B of net new capital in Q2 2024, opening 748 new positions and adding to 792 existing holdings. Its largest new stake was GE Vernova: 2,330,887 shares worth $400M.
By sector, the portfolio is most concentrated in Technology at 19% of assets, up from 16% a quarter earlier, followed by Consumer Discretionary and Healthcare.
On the sell side, the largest reduction was Procter & Gamble, an estimated $474M trimmed.
- Marshall Wace's largest Q2 2024 buy was GE Vernova: 2,330,887 shares worth $400M.
- Marshall Wace added most to iShares Core S&P 500 ETF in Q2 2024, an estimated $3.04B increase.
- Marshall Wace's biggest Q2 2024 reduction was Procter & Gamble, cutting an estimated $474M.
- Marshall Wace fully exited Applied Materials in Q2 2024, selling an estimated $127M.
- Marshall Wace's ten largest holdings make up 33% of its $74.9B portfolio in Q2 2024.
- Marshall Wace opened 748 new positions and closed 654 in Q2 2024.
- Marshall Wace's portfolio value rose 14% quarter-over-quarter to $74.9B.
Based on Marshall Wace's 13F filing for Q2 2024, filed 14 Aug 2024.